AI assistant
TherapeuticsMD, Inc. — Director's Dealing 2023
May 4, 2023
35134_dirs_2023-05-04_02d3240c-b00b-4dc6-aaeb-5c3a93f0d3a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2023-04-12
Reporting Person: Walker Marlan D (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-04-26 | Common Stock | M | 1010 | $0.00 | Acquired | 14041 | Direct |
| 2023-04-26 | Common Stock | M | 1734 | $0.00 | Acquired | 12307 | Direct |
| 2023-04-26 | Common Stock | S | 692 | $3.6381 | Disposed | 11615 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-26 | Restricted Stock Units | $0.00 | M | 1010 | Disposed | Common Stock (1010) | Direct | |
| 2023-04-26 | Restricted Stock Units | $0.00 | M | 1734 | Disposed | Common Stock (1734) | Direct |
Footnotes
F1: The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023.
F2: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
F3: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.
F4: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.